Clinical Trials Logo

Citation(s)

Injections of Botulinum Toxin A or Anticholinergic Treatment as First Line Therapy to Treat Neurogenic Overactive Bladder in Patients With Multiple Sclerosis

Details for clinical trial NCT04819360